
Orion
Finnish company developing pharmaceuticals and diagnostic tests.
Enterprise value
$9.9b
Share price
€63.85 ORNBV.HE
Company register number
1999212-6
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
$290m | Growth Equity non VC | ||
Total Funding | 000k |
EUR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | (3 %) | 29 % | (11 %) | 30 % | 8 % | 21 % | (5 %) |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 27 % | 36 % | 27 % | 27 % | 31 % | 34 % | 30 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 19 % | 26 % | 18 % | 21 % | 22 % | 25 % | 22 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 11 % | 10 % | 11 % | 12 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Orion
Edit
ACQUISITION by Orion Mar 2017

ACQUISITION by Orion Jun 2022

ACQUISITION by Orion Mar 2017